Telzuit Medical Technologies: Technology Update
Telzuit Medical Technologies, Inc. (OTCBB: TZMT) announced that it has been successful in running Windows Mobile 5.0 PDA devices exclusively on batteries while storing the cardiac data to removable memory cards. Both the HTC 8525 and the Samsung Black Jack run effectively for 24 hours without the need to charge the PDA. We are currently testing the Palm devices for this capability.
The 24-hour completely wireless capability will enable the patient to be completely wireless during the entire holter exam. Although we will recommend that patients charge the device while sleeping, more active patients will be able to complete the exam without having to charge the PDA.
Testing on healthy human subjects is continuing.
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company’s web site: http://www.telzuit.com.
Forward-Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
Contact: Jerry Balter Chief Financial Officer Telzuit Medical Technologies, Inc. 407-354-1222
SOURCE: Telzuit Medical Technologies, Inc.